Article #31081
Fox News - Top Stories
| Title | New drug approach offers hope for patients with recurrent aggressive cancers | Source | Fox News - Top Stories |
| Description | Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients. | ||
| Link | https://www.foxnews.com/health/new-drug-approach-offers-hope-patients-recurrent-aggressive-cancers | Published At | 2026-05-20 07:00:20 (1 month ago) |
| Created At | 2026-05-20 07:08:20 | Updated At | 2026-05-20 07:08:20 |